Join us today  to:

• Hear latest regulatory updates for smooth and speedy  approval
• Learn successful biosimilar case studies to reshape your business model
• Dissect regional market growth opportunities - where should you go next ?
• Network with like-minded senior experts and engage in interactive debates

Elite Speaker Panel 2016:

• Edric Engert, Senior Vice President, Biosimilars, Teva Pharmaceuticals

• Gustavo Grampp, Ph.D., Director R&D Policy - Biosimilars, Amgen Inc.

• Hillel Cohen, Executive Director, Scientifi c Affairs, Sandoz

• Andrew Simpson, Scientifi c Director, Orygen Biotechnologia S/A

• Dr. Jianguo Yang, CEO, Abpro-China; Vice President, Abpro-US

• Daniel Alvarez, Senior Director, Asset Lead, Global Established Pharma, Pfizer Inc.